Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

Michael O'Riordan

May 12, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Daily News

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Shelley Wood

July 19, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News ACC 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

Todd Neale

March 09, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

Advertisement

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Debating the Role of T-TEER in the Sickest Patients

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

ESC Congress 2011: Drugs, Devices Work Together

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content